Linomide-induced suppression of experimental autoimmune neuritis is associated with down-regulated macrophage functions

Journal of Neuroimmunology

Volumn 76, Issue 1-2, 1997, Pages 177-184

  Bai, Xue Feng ^a   Shi, Fu Dong ^a   Zhu, Jie ^a   Xiao, Bao Guo ^a   Hedlund, Gunnar ^b   Link, Hans ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Pharmacia & Upjohn AB   (Sweden)

Author keywords

Cytokine; Experimental autoimmune neuritis; Guillain Barre syndrome; Linomide; Macrophage

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; ROQUINIMEX; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GUILLAIN BARRE SYNDROME; IMMUNOMODULATION; MACROPHAGE; MALE; NEURITIS; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DOWN-REGULATION; HYDROXYQUINOLINES; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; NITRIC OXIDE; RATS; RATS, INBRED LEW; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030952824     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00051-9     Document Type: Article

References (26)

1. Arad G., Katzenellenbogen M., Levy R., Slavin S., Kaempfer R. Linomide, an immunomodulator that inhibits Th1 cytokine gene expression. Int. Immunol. 8:1996;1603-1607.
2. Bjork J., Kleinau S. Paradoxical effects of LS-2616 (Linomide) treatment in the type II collagen arthritis model in mice. Agents Actions. 27:1989;319-321.
3. Dijkema R., van der Meide P.H., Dubbeld M., Wubben J., Schellekens H. Cloning expression and purification of rat IFN-γ Methods Enzymol. 119:1986;453-463.
4. Gonzalo J.A., Gonzalez-Garcia A., Kalland T., Hedlund G., Martinez-A C., Kroemer G. Linomide, a novel immunomodulator that prevents death in four models of septic shock. Eur. J. Immunol. 23:1993;2372-2374.
5. Gross D.J., Sidi H., Weiss L., Kalland T., Rosenmann E., Slavin S. Prevention of diabetes mellitus in non-obese diabetic mice by Linomide, a novel immunomodulating drug. Diabetologia. 37:1994;1195-1201.
6. Hartung H.P., Pollard J.D., Harvey G.K., Toyka K.V. Immunopathogenesis and treatment of the Guillain-Barré syndrome part I. Muscle Nerve. 18:1995;137-153.
7. Henttinen T., Levy D.E., Silvennoinen O., Hurme M. Activation of signal transducer and transcription (STAT) signalling pathway in a primary T-cell response. Critical role for IL-6. J. Immunol. 155:1995;4582-4587.
8. Holsti M.A., McArthur J., Allison J.P., Raulet D.H. Role of IL-6, IL-1 and CD28 signalling in responses of mouse CD4+ T-cells to immobilised anti-TCR monoclonal antibody. J. Immunol. 152:1994;1618-1628.
9. Kalland T., Alm G., Stalhandske T. Augmentation of mouse natural killer activity by LS-2616, a new immunomodulator. J. Immunol. 134:1985;3956-3961.
10. Kalland T. Regulation of natural killer progenitors. Studies with a novel immunomodulator with distinct effects at the precursor level. J. Immunol. 144:1990;4472-4476.
11. Karussis D.M., Lehmann D., Slavin S., Vourka-Karussis U., Mizrachi-Koll R., Ovadia H., Ben-Nun A., Kalland T., Abramsky O. Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator Linomide. Ann. Neurol. 34:1993;654-660.
12. Karussis D.M., Lehmann D., Slavin S., Vourka-Karussis U., Mizrachi-koll R., Ovadia H., Kalland T., Abramsky O. Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator Linomide (quinoline-3-carboxamide). Proc. Natl. Acad. Sci. USA. 90:1993;6400-6404.
13. Karussis D.M., Lehmann D., Brenner T., Wirguin I., Mizrachi-Koll R., Sicsic C., Abramsky O. Immunomodulation of experimental autoimmune myasthenia gravis with Linomide. J. Neuroimmunol. 55:1994;187-193.
14. Kraemer, Y.I., Lopez, R.D., Reaven, G.M., 1985. Effects of noninsulin-dependent diabetes mellitus on the uptake of very low density lipoproteins by thioglycolate elicited mouse peritoneal macrophages. J. Clin. Endocrinol. Metab., 61-335.
15. Lindström J., Einarson B., Tzartos S. Production and assay of antibodies to acetylcholine receptors. Methods Enzymol. 74:1981;432-460.
16. Norton W.I., Poduslo S.E. Myelination in rat nerve: Method of myelin isolation. J. Neurochem. 21:1973;749-757.
17. Plebanski M., Elson C.J., Billington W.D. Dependency on interleukin-1 of primary human in vitro T-cell responses to soluble antigens. Eur. J. Immunol. 22:1992;2353-2358.
18. Said G., Hontebeyrie-Joskowicz M. Nerve lesions induced by macrophage activation. Res. Immunol. 143:1992;589-599.
19. Schmidt B., Stoll G., Hartung H.P., Heininger K., Schäfer B., Toyka K.V. Macrophages but not Schwann cells express Ia antigen in experimental autoimmune neuritis. Ann. Neurol. 28:1990;70-77.
20. Stoll G., Jung S., Jander S., van der Meide P., Hartung H.P. Tumor necrosis factor-a in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J. Neuroimmunol. 45:1993;175-182.
21. Tarkowski A., Gunnarsson K., Nilsson L.A., Lindholm L., Stalhandske T. Successful treatment of autoimmunity in MRL/l mice with LS-2616, a new immunomodulator. Arthritis Rheum. 29:1986;1405-1409.
22. Vukanovic J., Isaacs J.T. Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers. Cancer Res. 55:1995;1499-1504.
23. Xiao B.G., Bai X.F., Zhang G.X., Höjeberg B., Link H. Shift from anti- to proinflammatory cytokine profiles in microglia through LPS- or IFN-γ-mediated pathways. Neuroreport. 7:1996;1893-1898.
24. Zhang, G.X., Shi, F.D., Xiao, B.G., Björk, J., Hedlund, G., Link, H., 1996. Linomide suppresses both Th1 and Th2 cytokines in experimental autoimmune myasthenia gravis. J. Neuroimmunol., in press.
25. Zhu J., Mix E., Issazadeh S., Link H. Dynamics of mRNA expression of interferon-g, interleukin 4 and transforming growth factor b1 in sciatic nerves and lymphoid organs in experimental allergic neuritis. Eur. J. Neurol. 3:1996;1-9.
26. Zielasek J., Jung S., Gold R., Liew F.Y., Toyka K.V., Hartung H.P. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58:1995;81-88.